Intangible Assets, Net (Excluding Goodwill) in USD of INTERFACE INC from Q1 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
Summary
Interface Inc quarterly Intangible Assets, Net (Excluding Goodwill) history and change rate from Q1 2020 to Q3 2025.
  • Interface Inc Intangible Assets, Net (Excluding Goodwill) for the quarter ending September 28, 2025 was $50.6M, a 4.17% decline year-over-year.
Intangible Assets, Net (Excluding Goodwill), Quarterly (USD)
Intangible Assets, Net (Excluding Goodwill), YoY Quarterly Change (%)

INTERFACE INC Quarterly Intangible Assets, Net (Excluding Goodwill) (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $50.6M -$2.2M -4.17% Sep 28, 2025 10-Q 2025-11-04
Q2 2025 $51.1M -$1M -1.92% Jun 29, 2025 10-Q 2025-08-05
Q1 2025 $48.7M -$5.1M -9.48% Mar 30, 2025 10-Q 2025-05-06
Q4 2024 $48.3M -$7.96M -14.1% Dec 29, 2024 10-Q 2025-11-04
Q3 2024 $52.8M -$2.5M -4.52% Sep 29, 2024 10-Q 2024-11-05
Q2 2024 $52.1M -$6.2M -10.6% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $53.8M -$5.4M -9.12% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $56.3M -$3.52M -5.89% Dec 31, 2023 10-K 2025-02-26
Q3 2023 $55.3M -$6.7M -10.8% Oct 1, 2023 10-Q 2023-11-07
Q2 2023 $58.3M -$8.9M -13.2% Jul 2, 2023 10-Q 2023-08-08
Q1 2023 $59.2M -$13.4M -18.5% Apr 2, 2023 10-Q 2023-05-09
Q4 2022 $59.8M -$16.4M -21.5% Jan 1, 2023 10-K 2024-02-28
Q3 2022 $62M -$17M -21.5% Oct 2, 2022 10-Q 2022-11-08
Q2 2022 $67.2M -$15.2M -18.4% Jul 3, 2022 10-Q 2022-08-09
Q1 2022 $72.6M -$10.6M -12.7% Apr 3, 2022 10-Q 2022-05-10
Q4 2021 $76.2M Jan 2, 2022 10-K 2023-03-01
Q3 2021 $79M -$6.5M -7.6% Oct 3, 2021 10-Q 2021-11-09
Q2 2021 $82.4M Jul 4, 2021 10-Q 2021-08-10
Q1 2021 $83.2M +$500K +0.61% Apr 4, 2021 10-Q 2021-05-11
Q3 2020 $85.5M Oct 4, 2020 10-Q 2020-11-09
Q1 2020 $82.7M Apr 5, 2020 10-Q 2020-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.